Hillsdale Investment Management Inc. Purchases 5,400 Shares of Tenet Healthcare Corporation $THC

Hillsdale Investment Management Inc. lifted its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 31.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,800 shares of the company’s stock after purchasing an additional 5,400 shares during the period. Hillsdale Investment Management Inc.’s holdings in Tenet Healthcare were worth $4,629,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. William B. Walkup & Associates Inc. bought a new position in shares of Tenet Healthcare during the 3rd quarter worth approximately $32,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare during the second quarter worth $35,000. Westside Investment Management Inc. raised its position in shares of Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after purchasing an additional 96 shares during the period. Trust Co. of Vermont bought a new stake in shares of Tenet Healthcare during the 3rd quarter worth about $41,000. Finally, Caitong International Asset Management Co. Ltd raised its holdings in Tenet Healthcare by 2,227.3% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company’s stock valued at $45,000 after acquiring an additional 245 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the transaction, the director owned 28,480 shares in the company, valued at $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.81% of the stock is owned by company insiders.

Tenet Healthcare Price Performance

THC stock opened at $229.56 on Friday. The company’s 50-day moving average price is $201.87 and its two-hundred day moving average price is $197.42. The firm has a market cap of $19.96 billion, a P/E ratio of 14.82, a P/E/G ratio of 1.13 and a beta of 1.44. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $235.77.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. During the same period last year, the firm posted $3.44 earnings per share. The firm’s quarterly revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Analysts Set New Price Targets

THC has been the topic of several research reports. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $265.00 target price on shares of Tenet Healthcare in a research report on Monday, February 16th. JPMorgan Chase & Co. upped their price objective on Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Royal Bank Of Canada lifted their target price on Tenet Healthcare from $253.00 to $277.00 and gave the stock an “outperform” rating in a report on Thursday, February 12th. KeyCorp raised their price target on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Thursday, February 12th. Finally, UBS Group increased their target price on shares of Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and an average target price of $247.67.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.